Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families-Reference-Cited by-同舟云学术

Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

Published:2019-04-04 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Shahi Rajendra Bahadur^ORCID,De Brakeleer Sylvia,Caljon Ben,Pauwels Ingrid,Bonduelle Maryse,Joris Sofie,Fontaine Christel,Vanhoeij Marian,Van Dooren Sonia,Teugels Erik,De Grève Jacques

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5494-7.pdf

Reference48 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

2. Rahman N, Stratton MR. The genetics of breast cancer susceptibility. Annu Rev Genet. 1998;32:95–121.

3. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250(4988):1684–9.

4. Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497–506.

5. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66–71.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of genomic and epigenomic alterations of multigene on a multicancer pedigree;Cancer Medicine;2024-07

2. Understanding the Landscape of Clinically Available Molecular Testing;Surgical Oncology Clinics of North America;2024-04

3. Identification and validation of hub genes and molecular classifications associated with chronic myeloid leukemia;Frontiers in Immunology;2024-01-12

4. Capabilities of Molecular Genetic Methods for Effective Hereditary Cancers Detection in Individuals with High Cancer Risk Factors;City Healthcare;2023-06-19

5. The diagnosis of hereditary cancer syndromes with atypical manifestation: clinical cases;Malignant tumours;2023-05-16